Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Leishmaniasis, Cutaneous

• Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis
• Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis
• Combination, Miltefosine Monotherapy & Antimonial Therapy for Cutaneous Leishmaniasis in New World
• Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)
• Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.
• Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects
• Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis
• Miltefosine Plus IL Pentamidine for Bolivian CL
• Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
• Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia
• Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients
• Miltefosine and GM-CSF in Cutaneous Leishmaniasis
• Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis
• A Study of a New Leishmania Vaccine Candidate ChAd63-KH
• Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
• Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
• The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
• Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients
• WR 279,396 for the Treatment of Cutaneous Leishmaniasis
• High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
• Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia
• Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
• Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India
• Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis
• A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis
• WR 279,396 Open Label Treatment Protocol in Tunisia
• Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
• Pharmacokinetics of Miltefosine in Children and Adults
• Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
• Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis
• Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony
• Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
• Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
• Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
• Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama
• Miltefosine to Treat Mucocutaneous Leishmaniasis
• Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis
• Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)
• A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis
• Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients
• Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis
• Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul
• Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis
• Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients
• Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
• Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis
• Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396
• Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
• Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
• Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
• Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
• Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application
• Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
• Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
• Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.
• Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
• Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica
• Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
• Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
• Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
• Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
• Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil